TRAVERE THERAPEUTICS INC shareholders Q2 2023

TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422G957. A total of 4 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

TRAVERE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 30,800$473,0880.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SIMPLEX TRADING, LLC 1,100$160.00%
JANE STREET GROUP, LLC 37,600$577,5360.00%

This page lists TRAVERE THERAPEUTICS INC's shareholders in Q2 2023. To view TRAVERE THERAPEUTICS INC's shareholder history, click here.